SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
50078My caption (below) was very close to one of the finalists. This has happened sevDaveAu26/25/2018
50077[OT] Also Don Shimoda?glass 0.5 full-6/25/2018
50076[OT]—Has anyone heard from Tom Pope? The post I'm replying to is his latest.DewDiligence_on_SI-6/25/2018
50075>>look for a way to strengthen the blood brain barrier No easy at all - iBiomaven-6/24/2018
50074Hi Dave, Re: Arterial health............. A very low tech way is adding some coOldAIMGuy-6/23/2018
50073Is it conceivable to look for a way to strengthen the blood brain barrier, somehDaveAu-6/23/2018
50072That paper suggests that a mRNA miR-155 may play a key part here - its levels arBiomaven-6/22/2018
50071AD & microbial infection... Alzheimer’s may be caused by brain’s sticky defbiocqr26/22/2018
50070AD and herpes virus... Derek Lowe: Alzheimer’s and Infectious Disease: For Realbiocqr-6/22/2018
50069another microbiome focused biotech... Kallyope At Kallyope, we are focused on biocqr-6/20/2018
50068re: NTEC Does anyone here follow NTEC? Comments? BladerunnerBladerunner17-6/20/2018
50067Yes it does sound that way doesn’t it??? The CEO Dr. Jennifer Bath has them at 31Floors-6/20/2018
50066IPA -- If it sounds too good to be true, maybe it is. At least they have probablArt Bechhoefer-6/19/2018
50065Check out IPA / IPATF (C$1.20) IPA June Presentation IPA has 67m shares FD (p31Floors-6/19/2018
50064[graphic]teevee-6/16/2018
50063CFRX behaving well the last couple of days....teevee-6/15/2018
50062Microbiome foucused biotechs... Seres (MCRB) Seres Therapeutics’ proprietary dibiocqr26/13/2018
50061Will flickering light treat Alzheimer’s disease ? luysii.wordpress.com Big phabiocqr-6/13/2018
50060Cortexyme's AD study inclusion criteria...periodontitis. A Multiple Ascendibiocqr-6/13/2018
50059It took Catalyst (CPRX) a little over 2 yrs to move CPP-115 to the clinic after biocqr-6/11/2018
50058OVID -- Last week there was an OVID presentation mainly on its two epilepsy drugArt Bechhoefer-6/11/2018
50057Thanks for looking into the OV329 compound. I think that almost anything in precArt Bechhoefer-6/11/2018
50056OVID, OV329 > So OV329 is 10X more effective than Catalyst's CP-155.... biocqr16/11/2018
50055Ovid Therapeutics (OVID) -- An article in Science (AAAS) about 2 months ago mentArt Bechhoefer16/11/2018
50054CMO pay $242K, CEO $842K, when I see thinks like this I said: FUCXX THEM!Miljenko Zuanic16/11/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News